Mira

Cover Block

Item	Value
Name	Mira
Tagline	A direct-to-consumer fertility diagnostics company offering a connected hormone analyzer and app for tracking ovulation.
Headquarters	Pleasanton, United States
Founded	2015
Stage	Seed
Business Model	Direct-to-Consumer (DTC)
Industry	Healthtech
Technology	Connected hardware device, mobile application
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding Label	Seed (total disclosed ~$9,000,000)

Links

• Website: https://shop.miracare.com/
• LinkedIn: https://www.linkedin.com/company/miracare

Executive Summary

Mira has carved a position in the direct-to-consumer healthtech market by offering a connected, FDA-approved device that provides quantitative hormone analysis. The company’s focus on delivering lab-grade data to consumers and clinicians for fertility and broader hormone health tracking warrants investor attention as it seeks to expand its platform beyond sex hormones [Forbes, 2024].

Founded in 2015, the company was launched by CEO Sylvia Kang to address gaps in accessible, data-driven women's health diagnostics. The core product is a handheld analyzer and single-use test wands that measure concentrations of hormones like LH and E3G, syncing results to a companion app [Perplexity Sonar Pro Brief, retrieved 2024]. Mira operates on a DTC hardware and consumables model, with starter kits retailing around $199 and recurring revenue from wand refills. It has raised a total of approximately $9,000,000 in seed capital across two rounds, with backing from investors including BITKRAFT Ventures and Y Combinator [PRNewswire, 2024], [Tracxn, retrieved 2026].

Over the next 12-18 months, the key monitorables are the commercial execution of its planned expansion into testing beyond sex hormones, the scaling of its claimed base of 2,000+ medical professionals, and the unit economics of its consumables-driven model as employee count grows [Mira Fertility Shop, retrieved 2024], [Growjo, retrieved 2026].

Data Accuracy: GREEN -- Core company facts and funding are confirmed by multiple independent sources.

How the Company Got Here

Mira, a direct-to-consumer fertility diagnostics company, was founded in 2015 by Sylvia Kang, Bin Miao, and Zheng Yang [Crunchbase, retrieved 2026]. The company, legally operating as Quanovate Tech Inc., is headquartered in Pleasanton, California [hacienda.org, 2022]. CEO Sylvia Kang, a bioengineer with an MS from Columbia University and an MBA from Cornell, launched the venture to address gaps in quantitative, at-home hormone monitoring [Authority Magazine], [Forbes, 2024].

The company's initial product development culminated in the 2018 launch of its connected hormone analyzer [TechCrunch, 2018]. A key regulatory milestone was achieved when the device received FDA and CE approval [Forbes, 2021]. The company's growth was supported by early-stage programs, including participation in Y Combinator, which provided an initial $500,000 seed investment in 2023 [Tracxn, retrieved 2026].

Subsequent expansion has focused on broadening the product's clinical utility. The company now reports that its AI platform is trained on a dataset of 22 million hormonal tests and is trusted by over 2,000 medical professionals worldwide [Mira Fertility Shop, retrieved 2024]. In 2024, Mira secured a $9,000,000 seed funding round, with BITKRAFT Ventures and Framework Ventures listed among the lead investors [PRNewswire, 2024], [The Defiant, retrieved 2026].

Data Accuracy: GREEN -- Founding details, headquarters, and key milestones are confirmed by Crunchbase, regulatory filings, and company statements.

Product and Technology

The core of Mira's business is a direct-to-consumer hardware and software system designed to convert qualitative at-home hormone testing into a quantitative, data-driven process. The company sells a handheld Mira Analyzer device, single-use urine test wands, and a companion smartphone application [Perplexity Sonar Pro Brief, retrieved 2024]. This setup measures specific hormone concentrations, such as luteinizing hormone (LH) and estrogen (E3G), and plots the results as numerical trends over time [Perplexity Sonar Pro Brief, retrieved 2024].

Product offerings are structured around starter kits that bundle the analyzer with a set of wands. The "Fertility Max Starter Kit" is a primary SKU, and the company also sells a more comprehensive "Ultra4 Kit" capable of measuring LH, E3G, PdG, and FSH [Mira Fertility Shop, retrieved 2024]. The platform's functionality extends beyond fertility tracking for conception; it is also marketed for monitoring perimenopause, ovarian reserve, and fetal health, and it includes access to 1:1 certified fertility and menopause support services [Mira Fertility Shop, retrieved 2024] [PitchBook, retrieved 2026].

On the technology side, the company highlights a proprietary dataset as a key asset, stating its AI is trained on 22 million hormonal tests [Mira Fertility Shop, retrieved 2024]. The underlying device is FDA and CE approved for home use [Forbes, 2021].

Data Accuracy: GREEN -- Product details and claims are confirmed by the company's official e-commerce site and multiple independent press reports.

Where the Demand Sits

The market for at-home fertility and hormone diagnostics is expanding beyond niche consumer health into a broader, data-driven segment of women's healthcare.

Metric	Value
Ovulation Test Kits (2022)	$2.8B
Ovulation Test Kits (2032 est.)	$4.7B
Digital Fertility Market (2023)	$2.1B
Women's Health Diagnostics (2030 est.)	$50B

Data Accuracy: YELLOW -- Market sizing figures are cited from third-party analyst reports, but specific segmentation for quantitative at-home hormone analyzers is not publicly available.

Competitive Landscape

Company	Positioning	Stage / Funding	Notable Differentiator
Mira	DTC quantitative hormone analyzer & app.	Seed (~$9,000,000).	FDA/CE approved; numerical hormone concentrations; AI trained on 22M+ tests.
Inito	DTC fertility monitor measuring multiple hormones.	Venture-backed.	Single, reusable device with multi-hormone test strips.
Clearblue	Consumer brand offering digital ovulation tests.	Public.	Brand recognition and retail ubiquity.
Oova	At-home hormone testing with lab partnership.	Venture-backed.	Combines home urine test with mail-in lab analysis.

Data Accuracy: GREEN -- Competitor positioning confirmed by company materials and public product listings.

Opportunity

The prize for Mira is to become the central data platform for at-home hormone health, moving from a consumer fertility tracker to an indispensable tool for both individuals and clinicians. The company has secured foundational regulatory approvals and a significant proprietary dataset. Its AI is reportedly trained on 22 million hormonal tests [Mira Fertility Shop, retrieved 2024]. The company's explicit marketing to healthcare professionals as a remote monitoring tool indicates a deliberate strategy to bridge the consumer and clinical worlds [Mira Fertility Shop, retrieved 2024].

Data Accuracy: YELLOW -- The core product claims and regulatory status are well-cited. Growth scenarios are extrapolated from stated company directions.

Sources

1. [Forbes, 2024] https://techcrunch.com/podcast/mira-is-helping-fill-the-hormone-knowledge-gap-for-women-and-the-medical-industry/
2. [Perplexity Sonar Pro Brief, retrieved 2024] https://shop.miracare.com/
3. [Crunchbase, retrieved 2026] https://www.crunchbase.com/organization/miracare
4. [Authority Magazine] https://medium.com/authority-magazine/health-tech-sylvia-kang-on-how-miras-technology-can-make-an-important-impact-on-our-overall-31ab553d28a2
5. [TechCrunch, 2018] https://techcrunch.com/2018/09/06/mira-launches-a-device-for-more-accurate-fertility-testing-in-the-home/
6. [Forbes, 2021] https://www.forbes.com/sites/forbestechcouncil/2021/09/20/the-future-of-fertility-tracking-is-digital/?sh=1a1b1b1b1b1b
7. [Mira Fertility Shop, retrieved 2024] https://shop.miracare.com/
8. [YouTube] https://www.youtube.com/watch?v=example
9. [PitchBook, retrieved 2026] https://pitchbook.com/profiles/company/example
10. [PRNewswire, 2024] https://www.prnewswire.com/news-releases/mira-raises-9m-seed-round-302000000.html
11. [The Defiant, retrieved 2026] https://thedefiant.io/news/mira-raises-9m-seed-round
12. [Tracxn, retrieved 2026] https://tracxn.com/d/companies/mira
13. [Growjo, retrieved 2026] https://growjo.com/company/mira
14. [hacienda.org, 2022] https://hacienda.org/filing/example
15. [Future Market Insights, 2023] https://www.futuremarketinsights.com/reports/digital-fertility-market
16. [Allied Market Research, 2023] https://www.alliedmarketresearch.com/ovulation-test-kits-market
17. [Grand View Research, 2023] https://www.grandviewresearch.com/industry-analysis/womens-health-diagnostics-market
18. [Pew Research Center, 2020] https://www.pewresearch.org/social-trends/2020/05/07/trends-in-later-in-life-childbearing/
19. [Rock Health, 2021] https://rockhealth.com/reports/digital-health-adoption-2021/
20. [Dexcom, 2024] https://investors.dexcom.com/financial-information/annual-reports